4//SEC Filing
Gaslightwala Abizer 4
Accession 0001641172-25-026025
CIK 0001541157other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:55 PM ET
Size
9.7 KB
Accession
0001641172-25-026025
Insider Transaction Report
Form 4
Gaslightwala Abizer
Director
Transactions
- Purchase
American Depositary Shares representing Ordinary Shares
2025-08-21$0.94/sh+10,000$9,400→ 287,574 total - Purchase
American Depositary Shares representing Ordinary Shares
2025-08-25$0.90/sh+3,000$2,700→ 298,574 total - Purchase
American Depositary Shares representing Ordinary Shares
2025-08-22$0.93/sh+8,000$7,440→ 295,574 total
Footnotes (4)
- [F1]Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.
- [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.94, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.92 to $0.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.
Documents
Issuer
Akari Therapeutics Plc
CIK 0001541157
Entity typeother
Related Parties
1- filerCIK 0002049375
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:55 PM ET
- Size
- 9.7 KB